Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Drug Boosts PSMA-PET Signal for Prostate Cancer in Small Study

Drug Boosts PSMA-PET Signal for Prostate Cancer in Small Study
ShareXFacebook

(MedPage Today) -- A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a subset of patients with high-risk localized prostate cancer, according to findings from the phase II Daro...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Trump Unveils 100% Tariff on Some Patented Drugs
MedPage Today

Trump Unveils 100% Tariff on Some Patented Drugs

(MedPage Today) -- President Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don't reach deals with his administration in the coming months...

Read more →
Advertisement